X
LGND icon

Xponance’s Ligand Pharmaceuticals LGND Stock Holding History

Xponance’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$798K Buy
2,526
+687
+37% +$162K ﹤0.01% 877
2026
Q1 		$367K Buy
1,839
+303
+20% +$59.9K ﹤0.01% 1165
2025
Q4 		$290K Buy
1,536
+37
+2% +$7.11K ﹤0.01% 1202
2025
Q3 		$266K Buy
+1,499
New +$223K ﹤0.01% 1227
2021
Q3 		– Sell
-4,091
Closed -$335K – 1209
2021
Q2 		$335K Buy
4,091
+1,166
+40% +$97K 0.01% 1045
2021
Q1 		$278K Sell
2,925
-453
-13% -$42.8K 0.01% 977
2020
Q4 		$210K Sell
3,378
-49
-1% -$2.79K ﹤0.01% 1029
2020
Q3 		$204K Buy
3,427
+54
+2% +$3.69K 0.01% 977
2020
Q2 		$235K Buy
+3,373
New +$214K 0.01% 911

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Xponance's LGND Position: Q2 2026 in Review

Xponance increased its Ligand Pharmaceuticals (LGND) stake by 37% in Q2 2026, buying an estimated $162K and bringing the position to 2,526 shares worth $798K. The position accounts for ﹤0.01% of the portfolio, ranked #877.

Xponance first reported a position in LGND in Q2 2020 and has held it in 9 quarters since. 417 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Xponance held 2,526 shares of Ligand Pharmaceuticals worth $798K as of Q2 2026.
  • Xponance bought 687 Ligand Pharmaceuticals shares in Q2 2026, an estimated $162K.
  • Ligand Pharmaceuticals made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #877 holding.
  • Xponance first reported a position in Ligand Pharmaceuticals in Q2 2020 and has held it in 9 quarters since.
  • 417 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.